跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
力备 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ropinirole Hydrochloride Sustained-release Tablets
Approved
化学药品
Ropinirole Hydrochloride Sustained-release Tablets
GLAXOSMITHKLINE SA
🇨🇳 National Medical Products Administration
Approval Date
Jun 13, 2025
Approval ID
81u8kAgemHD
Company
GLAXOSMITHKLINE SA
Type
化学药品
Approval Details
Approval Id
81u8kAgemHD
Approval Number
国药准字HJ20150415
Generic Name
盐酸罗匹尼罗缓释片
Generic Name En
Ropinirole Hydrochloride Sustained-release Tablets
Brand Name
力备
Drug Type
化学药品
Dosage Form
片剂
Strength
4mg
Reg Date
2025-06-13
Expired Date
2030-06-12
Company Name
GLAXOSMITHKLINE SA
Company Detail Path
/organization/glaxosmithkline-sa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 13, 2025
Approval ID
81u8kAgemHD
Type
化学药品
Back to NMPA Approvals
